TEAD Inhibitors Sensitize KRASG12C Inhibitors via Dual Cell Cycle Arrest in KRASG12C-Mutant NSCLC.
Tammaccaro SL, Prigent P, Le Bail JC, Dos-Santos O, Dassencourt L, Eskandar M, Buzy A, Venier O, Guillemot JC, Veeranagouda Y, Didier M, Spanakis E, Kanno T, Cesaroni M, Mathieu S, Canard L, Casse A, Windenberger F, Calvet L, Noblet L, Sidhu S, Debussche L, Moll J, Valtingojer I.
Tammaccaro SL, et al. Among authors: eskandar m.
Pharmaceuticals (Basel). 2023 Apr 6;16(4):553. doi: 10.3390/ph16040553.
Pharmaceuticals (Basel). 2023.
PMID: 37111311
Free PMC article.